$42.30
+3.47 (+8.94%)
At Close: Jun 24, 2026
Edgewise Therapeutics Launches First of Its Kind Educational Website Dedicated to the Becker Muscular Dystrophy Community
08:00am, Monday, 18'th Dec 2023
BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced the launch of an educational website dedicated to the
Sign In
Buy EWTX